Clinical Trial Update: Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a conditioning regimen combining thiotepa, busulfan, and fludarabine for haploidentical hematopoietic stem cell transplan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)
• THIOTEPA (THIOTEPA)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Acute Myeloid Leukemia (AML), High Risk Acute Myeloid Leukemia(AML) | Phase 2 | Status: RECRUITING